Department of Human Pathology, Wakayama Medical University, Kimiidera 811-1, Wakayama, 641-8509, Japan.
J Clin Endocrinol Metab. 2010 Mar;95(3):1309-17. doi: 10.1210/jc.2009-1794. Epub 2010 Jan 22.
IgG4-related sclerosing disease is a new syndrome characterized by high serum IgG4 levels and increased IgG4-positive plasma cells in the involved organs. Recently the first description was made by our group of a subsection of Hashimoto's autoimmune thyroiditis (HT) patients showing indistinguishable histopathological features with IgG4-related sclerosing disease, which was termed as IgG4 thyroiditis.
The objective of the study was analysis of the immunophenotypic features of IgG4 in 70 cases of HT patients and to clarify the histopathological and clinical characteristics of the patients with IgG4 thyroiditis.
Thyroid tissue samples were obtained from 70 patients with HT who were treated surgically. Quantitative analyses of the expression of IgG4 and IgG were performed. Statistical analyses of clinical and histopathological parameters were also conducted.
On the basis of immunohistochemistry of IgG4 and IgG4/IgG ratio, the 70 patients with HT were divided into two groups: IgG4 thyroiditis (19 cases) and non-IgG4 thyroiditis (51 cases). Histopathologically, IgG4 thyroiditis showed higher grade of stromal fibrosis, lymphoplasmacytic infiltration, and follicular cell degeneration than non-IgG4 thyroiditis. Moreover, these two groups were also demonstrated to be related with different clinical features, with IgG4 thyroiditis associated more with male gender, rapid progress, subclinical hypothyroidism, more diffuse low echogenicity, and higher level of circulating antibodies.
From both clinical and histopathological aspects, IgG4 thyroiditis and non-IgG4 thyroiditis were demonstrated to be distinct entities. Measuring serum IgG4 concentration provides a useful method of distinguishing IgG4 thyroiditis from non-IgG4 thyroiditis.
IgG4 相关硬化性疾病是一种新的综合征,其特征为血清 IgG4 水平升高,受累器官中 IgG4 阳性浆细胞增多。最近,我们的研究小组首次描述了一部分桥本氏自身免疫性甲状腺炎(HT)患者表现出与 IgG4 相关硬化性疾病无法区分的组织病理学特征,将其命名为 IgG4 甲状腺炎。
本研究旨在分析 70 例 HT 患者 IgG4 的免疫表型特征,并阐明 IgG4 甲状腺炎患者的组织病理学和临床特征。
从接受手术治疗的 70 例 HT 患者中获取甲状腺组织样本。对 IgG4 和 IgG 的表达进行定量分析。还对临床和组织病理学参数进行了统计分析。
根据 IgG4 和 IgG4/IgG 比值的免疫组化结果,70 例 HT 患者分为 IgG4 甲状腺炎(19 例)和非 IgG4 甲状腺炎(51 例)两组。组织病理学上,IgG4 甲状腺炎的间质纤维化、淋巴浆细胞浸润和滤泡细胞变性程度高于非 IgG4 甲状腺炎。此外,这两组还与不同的临床特征相关,其中 IgG4 甲状腺炎与男性、快速进展、亚临床甲状腺功能减退、更弥漫性低回声和更高水平的循环抗体有关。
从临床和组织病理学两方面来看,IgG4 甲状腺炎和非 IgG4 甲状腺炎是不同的实体。测量血清 IgG4 浓度是区分 IgG4 甲状腺炎和非 IgG4 甲状腺炎的一种有用方法。